パンキャンジャパン - 海外ニュース（英語版）English News 2006

メインメニュー

☆PanCAN　公式ブログ

パンキャンとは /About us

☆イベント情報　/Eventｓ

膵臓がん/Pancreatic Cancer

臨床試験　　　/Clinical Trials

膵がん専門病院　/Med Ctr

心のケア　/Onco-psychology

介護者支援　/Caregiver

患者の声 /Survivor

医療セミナー/Seminar

勉強会　/Study Session

電話相談 /Call Center

専門医に聞く/AskSpecialist　

研究支援　/Res Support

政策提言活動　/Public Policy

ストア/Store

会員募集　/Membership

ボランティア募集　/Volunteer

有益な情報源　/Useful Source

ニュース /News

ニュースフラッシュ/ Newsflash

お問い合わせ　/ContactUs

会員コーナー/MembersOnly

FacileForms
[No form id or name provided!]

海外ニュース（英語版）English News 2006

プリント

メール

作者 Administrator
2007/11/29 Thursday 14:27:19 JST
最新のニュース(英語版）をお届けします。＜Chemotherapy　Treatments＞ Threshold Pharmaceuticals Announces Top-Line Phase II Clinical Trials Results of Glufosfamide for Treatment of Pancreatic Cancer December 27, 2006 Source: PharmaLive Pancreatic Cancer Treated By Gemcitabine Plus Cisplatin October 26, 2006 Source: CancerCompass.com Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer August 20, 2006 Source: PubMed Threshold Pharmaceuticals Completes Enrollment in Phase 3 and Phase 2 Trials for the Treatment of Pancreatic Cancer August 8, 2006 Source: Threshold Pharmaceuticals Avantogen Oncology Inc. Announces Preliminary Results of a Dose Ranging Study of RP101 in Combination With Gemcitabine Chemotherapy in Patients With Advanced Pancreatic Cancer August 17, 2006 Source: genengnews.com Chemo-Radiation After Surgery for Pancreatic Cancer May Prolong Survival July 25, 2006 Source: cancerpage.com Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study July 25, 2006 Source: PubMed Combination Therapy May Improve Survival for Pancreatic Cancer July 20, 2006 Source: Newswise.com Gemzar® Combined with Eloxatin® or Platinol® Improves Survival for Patients with Advanced Pancreatic Cancer June 2006 Source: CancerConsultants.com Addition of Gemzar to Adjuvant Therapy Improves Survival in Pancreatic Cancer June 2006 Source: CancerConsultants.com Pancreatic Cancer With Gemcitabine Resistance Treated By Raltitrexed-eloxatin Salvage Chemotherapy May 18, 2006 Source: CancerCompass.com New Drug Combination Found to Be Effective in Gemcitabine-Resistant Metastatic Pancreatic Cancer April 18, 2006 Source: Pancreasweb.com Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinoma April, 2006 Source: PubMed GEMOX Active in Gemcitabine Refractory Pancreatic Cancer March 10, 2006 Source: Pancreasweb.com Temodar® and Thalomid® Effective for Metastatic Neuroendocrine Tumors March, 2006 Source: CancerConsultants.com Tomudex® Plus Eloxatin® Effective in Gemzar®-Resistant Metastatic Pancreatic Cancer March, 2006 Source: CancerConsultants.com A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients with Potentially Resectable Pancreatic Carcinoma February, 2006 Source: Annals of Surgical Oncology on PubMed Northwestern Researchers Launch Avastin Trial for Pancreatic Tumors February 22, 2006 Source: ScienceDaily New Study of Gemcitabine, Cisplatin and Bevacizumab Yields Promising Results February 3, 2006 Source: Pancreasweb.com New oral regimen active against pancreatic neuroendocrine tumors February 1, 2006 Source: OncoLink Gemcitabine plus platinum analog extends life in pancreatic cancer January 27, 2006 Source: OncoLink 5-fluorouracil And Gemcitabine Enhance Gene Therapy in Pancreatic Cancer January 26, 2006 Source: Cancer Compass Bevacizumab plus Gemcitabine may Help Patients with Advanced Pancreatic Cancer December 29, 2005 Source: CancerCompass Pancreatic Cancer: Novel Approaches to Diagnosis and Therapy October 2005 Source: Gastroenterology on Pancreasweb.com Therapies That Modulate c-Src May Control Cancer Of The Pancreas September 15, 2005 Source: Cancer Compass FDA Advisory Panel Recommends Tarceva(R) Approval for Pancreatic Cancer September 13, 2005 Source: Yahoo OSI Gets Good News From FDA Panel September 13, 2005 Source: TheStreet.com Stage I Of The Phase II Trial With Metxia® In Pancreatic Cancer Completed August 7, 2005 Source: Medical News Today Point Therapeutics Initiates Phase 2 Clinical Trial of Talabostat in Advanced Pancreatic Cancer June 23, 2005 Source: Business Wire Chemotherapy vs. Chemoradiation for Pancreatic Cancer May 23, 2005 Source: PancreasWeb.com Phase III Study Of Tarceva In Combination With Chemotherapy Improves Survival In Pancreatic Cancer Patients Mat 14, 2005 Source: Genentech, Inc. OSI Pharmaceuticals And Genentech Announce Filing Of A Supplemental New Drug Application To The FDA For Tarceva In Pancreatic Cancer May 2, 2005 Source: Genentech, Inc. Full-Dose Gemcitabine Plus Radiation Shows Encouraging Results in Pancreatic Cancer April 15, 2005 Source: PancreasWeb.com Phase 3 Trial of Insegia in Pancreatic Cancer Does Not Meet Primary Endpoint February 15, 2005 Source: Aphton Corporation Data From Phase III Study Show Tarceva Plus Gemcitabine Significantly Improves Survival Compared To Gemcitabine Alone In Advanced Pancreatic Cancer Patients January 27, 2005 Source: Genentech, Inc. Vion Pharmaceuticals Provides Update On Triapine(R)-Gemcitabine Trial In Pancreatic Cancer December 14, 2004 Source: Vion Pharmaceuticals Tarceva Plus Gemcitabine Improves Survival Compared to Gemcitabine Alone in First-Line Pancreatic Cancer Patients September 20, 2004 Source: Genentech, Inc. COX-2 inhibitors have therapeutic potential in pancreatic cancer July 1, 2004 Source: OncoLink The Addition of Eloxatin(TM) to gemcitabine Significantly Improves the Treatment of Advanced Pancreatic Cancer June 7, 2004 Source: PR Newswire SuperGen's New Drug Application for Orathecin Capsules Accepted by FDA for Filing March 26, 2004 Source: PR Newswire on MyCancerCompass.com Resectable pancreatic cancer needs surgery, then chemotherapy March 20, 2004 Source: bmj.com A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer March 18, 2004 Source: New England Journal of Medicine Adjuvant Therapy for Pancreatic Cancer — The Debate Continues March 18, 2004 Source: New England Journal of Medicine Adjuvant Chemotherapy Helpful for Completely Resected Pancreatic Cancer March 17, 2004 Source: Medscape Chemotherapy improves survival after resection of pancreatic cancer March 17, 2004 Source: Reuters Health on OncoLink Phase II Study of External Irradiation and Weekly Paclitaxel for Nonmetastatic, Unresectable Pancreatic Cancer: RTOG-98-12 February 2004 Source: American Journal of Clinical Oncology Medical Management of Pancreatic Cancer February 2004 Source: Medscape Chemotherapy for Pancreatic Cancer February 11, 2004 Source: Medscape N ew Developments in the Treatment of Locally Advanced Pancreatic Cancer February 6, 2004 Source: Veritas Medicine Bevacizumab has direct antivascular effects on human tumors January 26, 2004 Source: Reuters Health on OncoLink GenVec Presents New Data on TNFerade(TM) for Pancreatic Cancer Januart 23, 2004 Source: GenVec, Inc. Highlights of the Chemotherapy Foundation Symposium XXI Therapeutic Options for Pancreatic Cancer January 9, 2004 Source: Medscape Independent Review Of Orathecin Phase III Trial Supports Drug's Activity December 11, 2003 Source: NewRx.com on MyCancerCompass.com Independent review of Orathecin™ Phase III trial supports drug’s activity in pancreatic cancer patients who failed prior treatments Data presented at “Innovative Cancer Therapy for Tomorrow" symposium to be used as basis for registrational filing with FDA November 17, 2003 Source: SuperGen Adjuvant Multimodality with Gemcitabine versus 5-Fluorouracil in Pancreatic Cancer: Status of U.S. Intergroup Trial November 12, 2003 Source: OncoLink Aphton Corporation Reports Positive Results in Phase III Trial of G17DT as Monotherapy in Patients with Pancreatic Cancer October 30, 2003 Source: Aphton Combination Chemotherapy Helpful in Some Patients With Unresectable Pancreatic Cancer October 21, 2003 Source: Medscape Combination Chemotherapy and Surgery Improve Survival of Patients with Pancreatic Cancer October 21, 2003 Source: MyCancerCompass.com Prolonged gemcitabine infusion could improve pancreatic cancer outcomes September 26, 2003 Source: Reuters Health on OncoLink Fixed Dose Rate Gemcitabine Infusion May Be Best for Pancreatic Cancer September 17, 2003 Source: Medscape Pancreatic Neoplasms September 16, 2003 Source: Medscape A novel approach for advanced pancreatic cancer September 12, 2003 Source: Veritas Medicine Update on the Gemcitabine/Irinotecan Combination in Pancreatic Cancer September 12, 2003 Source: Veritas Medicine ZD9331 I.V. Is Equivalent To Gemcitabine In Patients With Pancreatic Cancer September 11, 2003 Source: NewsRx on MyCancerCompass.com Triple Therapy Is Promising in Pancreatic Cancer August 13, 2003 Source: Medscape Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer August 2003 Source: Journal of Clinical Oncology on PubMed Avastin(TM) Plus Gemzar® Appears Promising for Pancreatic Cancer July 30, 2003 Source: 411Cancer.com on Acurian Combination Chemotherapy, Hyperthermia Helpful in Pancreatic, Neuroendocrine Cancer July 17, 2003 Source: MedScape Update on oxaliplatin and gemcitabine in advanced pancreatic cancer July 11, 2003 Source: Veritas Medicine Irinotecan + Raltitrexed Beneficial For Advanced Pancreatic Adenocarcinoma July 10, 2003 Source: NewsRx on MyCancerCompass.com Fighting Pancreatic Cancer June 23, 2003 Source: Ivanhoe Newswire Follow-up Therapies Needed For Patients With Pancreatic Cancer June 18, 2003 Source: NEWSWISE/Medical News on MyCancerCompass.com Metastatic Pancreatic Cancer: Where Are We Going? June 13, 2003 Source: Veritas Medicine A Combination Of Interferon And Gemcitabine Reduces Pancreatic Tumor Growth June 5, 2003 Source: NewsRx on MyCancerCompass.com Gemcitabine vs. GEMOX (gemcitabine + oxaliplatin) in non-resectable pancreatic adenocarcinoma: Interim results of GERCOR/GISCAD intergroup Phase III June 2, 2003 Source: OncoLink A Phase III Trial comparing Gemcitabine plus Cisplatin vs. Gemcitabine alone in advanced pancreatic cancer June 2, 2003 Source: OncoLink
最終更新日 ( 2009/09/21 Monday 11:09:16 JST )

< 前へ		次へ >